Raras
Buscar doenças, sintomas, genes...
Adenoma secretor de aldosterona com doença neuromuscular complexa
ORPHA:369929CID-10 · E26.0OMIM 615474DOENÇA RARA

É uma condição genética que afeta o desenvolvimento do cérebro (neurodesenvolvimento), causada por alterações no gene CACNA1D. É classificada como "autossômica dominante", o que significa que apenas uma cópia alterada desse gene é suficiente para causar a condição. A maioria dessas alterações genéticas são novas (chamadas "de novo"), ou seja, não foram herdadas dos pais. Estudos mostraram que essas alterações fazem com que o gene funcione de forma excessiva ou diferente do normal (um mecanismo de "ganho de função"), causando a doença. Essa condição é caracterizada por atraso no desenvolvimento e/ou deficiência intelectual, transtorno do espectro autista, fraqueza muscular (hipotonia) e convulsões. Outras características relatadas incluem problemas hormonais (endócrinos), como o excesso de um hormônio chamado aldosterona (aldosteronismo primário) e baixo açúcar no sangue desde o nascimento devido a muito insulina (hipoglicemia hiperinsulinêmica congênita); comportamento de autoagressão; características faciais diferentes ou peculiares; e problemas no coração.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma condição genética que afeta o desenvolvimento do cérebro (neurodesenvolvimento), causada por alterações no gene CACNA1D. É classificada como "autossômica dominante", o que significa que apenas uma cópia alterada desse gene é suficiente para causar a condição. A maioria dessas alterações genéticas são novas (chamadas "de novo"), ou seja, não foram herdadas dos pais. Estudos mostraram que essas alterações fazem com que o gene funcione de forma excessiva ou diferente do normal (um mecanismo de "ganho de função"), causando a doença. Essa condição é caracterizada por atraso no desenvolvimento e/ou deficiência intelectual, transtorno do espectro autista, fraqueza muscular (hipotonia) e convulsões. Outras características relatadas incluem problemas hormonais (endócrinos), como o excesso de um hormônio chamado aldosterona (aldosteronismo primário) e baixo açúcar no sangue desde o nascimento devido a muito insulina (hipoglicemia hiperinsulinêmica congênita); comportamento de autoagressão; características faciais diferentes ou peculiares; e problemas no coração.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
2
pacientes catalogados
Início
Infancy
+ neonatal
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E26.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
14 sintomas
❤️
Coração
5 sintomas
🫘
Rins
4 sintomas
👂
Ouvidos
1 sintomas
🫁
Pulmão
1 sintomas
🦴
Ossos e articulações
1 sintomas

+ 14 sintomas em outras categorias

Características mais comuns

100%prev.
Hiperaldosteronismo
100%prev.
Hipocalemia
Muito frequente (99-80%)
100%prev.
Hipertensão
Frequência: 2/2
100%prev.
Renina circulante anormal
100%prev.
Atraso global do desenvolvimento
Muito frequente (99-80%)
100%prev.
Paralisia cerebral
Muito frequente (99-80%)
41sintomas
Muito frequente (10)
Frequente (23)
Ocasional (5)
Muito raro (2)
Sem dados (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 41 características clínicas mais associadas, ordenadas por frequência.

HiperaldosteronismoHyperaldosteronism
Muito frequente100%
HipocalemiaHypokalemia
Muito frequente (99-80%)100%
HipertensãoHypertension
Frequência: 2/2100%
Renina circulante anormalAbnormal circulating renin
Muito frequente100%
Atraso global do desenvolvimentoGlobal developmental delay
Muito frequente (99-80%)100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico2026171 papers
Linha do tempo
2026Hoje · 2026🧪 2011Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Not applicable.

CACNA1DVoltage-dependent L-type calcium channel subunit alpha-1DDisease-causing germline mutation(s) (gain of function) inAltamente restrito
FUNÇÃO

Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1D gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkyla

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (4)
NCAM1 interactionsRegulation of insulin secretionAdrenaline,noradrenaline inhibits insulin secretionSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Sinoatrial node dysfunction and deafness

A disease characterized by congenital severe to profound deafness without vestibular dysfunction, associated with episodic syncope due to intermittent pronounced bradycardia.

OUTRAS DOENÇAS (2)
aldosterone-producing adenoma with seizures and neurological abnormalitiessinoatrial node dysfunction and deafness
HGNC:1391UniProt:Q01668

Variantes genéticas (ClinVar)

328 variantes patogênicas registradas no ClinVar.

🧬 CACNA1D: NM_001128840.3(CACNA1D):c.698G>A (p.Gly233Asp) ()
🧬 CACNA1D: NM_001128840.3(CACNA1D):c.3323A>G (p.Tyr1108Cys) ()
🧬 CACNA1D: NM_001128840.3(CACNA1D):c.881T>G (p.Ile294Ser) ()
🧬 CACNA1D: NM_001128840.3(CACNA1D):c.2241C>G (p.Phe747Leu) ()
🧬 CACNA1D: NM_001128840.3(CACNA1D):c.6029A>G (p.Asp2010Gly) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Adenoma secretor de aldosterona com doença neuromuscular complexa

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Tau pathology in epilepsy: emerging mechanisms and translational opportunities.

Brain : a journal of neurology2026 Mar 23

The onset of epilepsy in adulthood occurs most commonly after 55 years of age. Given the ageing global population, this disorder represents an increasing burden on healthcare and society. The bidirectional link between epilepsy and dementia is a focus of intense research with underlying tau pathology highlighted as a potential mechanistic link. In this review, we examine the evidence for tau-related neurodegenerative processes in epilepsy beginning with how changes in biochemical and structural properties of the tau protein can lead to abnormal phosphorylation and pathological aggregation. We consider the role of tau in seizure occurrence and cognitive difficulties in experimental animal epilepsy models to human epileptic syndromes. Seizure prevalence is evaluated across established primary and secondary tauopathies to understand the associated hyperexcitability phenotype. We discuss the use of neurophysiology, metabolic imaging and novel fluid biomarkers as non-invasive measures of potential underlying neurodegeneration in epilepsy. It may, for example, be that these can be combined with remote measures of cognition and other physiological parameters to provide accurate longitudinal monitoring of cognition and underlying pathology. We also explore clinical trials that have targeted pathological tau accumulation in neurodegenerative conditions and consider an ongoing clinical study with sodium selenate, an enhancer of protein phosphatase enzyme PP2A, in people with epilepsy. These efforts signify a novel disease-modifying era with treatments that reduce seizures and modify cognitive outcomes in people with epilepsy. Our analysis of the literature underscores the need for more in-depth characterization of tau pathology, at biochemical and structural levels, in brain tissue and peripheral samples from people with epilepsy as an important step to deciphering the role of tau in the pathogenesis of epilepsy and related disorders. Examining the relationships between tau pathology and cognitive impairment in those with epilepsy provides critical perspectives on a potential causal tau pathomechanism that may have important roles in epileptogenesis and dementia.

#2

Follicle-dependent differential localization of adipokines in the letrozole-induced hyperandrogenized mouse ovary.

Histochemistry and cell biology2026 Mar 19

This study investigated whether ovarian adipokines exhibit uniform or stage-specific expression patterns across different follicular stages under hyperandrogenic conditions using a letrozole-induced polycystic ovary syndrome (PCOS) mouse model. Adult female mice received oral letrozole treatment for 21 days to induce hyperandrogenism, and ovarian tissues were analyzed by immunohistochemistry and western blot to examine the localization and expression of adiponectin (ADPN), adipoR1, adipoR2, leptin (Ob), leptin receptor (ObR), apelin (APLN), apelin receptor (APJ), chemerin, CMKLR1, and visfatin. Intense immunostaining for Ob, ObR, APJ, APLN, adipoR2, and visfatin was observed in primary, secondary, and Graafian follicles, whereas ADPN, adipoR1, and CMKLR1 showed reduced reactivity. In follicular cysts, adipoR2, APLN, APJ, and Ob were markedly upregulated compared with the corpus luteum of control ovaries, whereas ADPN, adipoR1, chemerin, CMKLR1, and ObR were downregulated. These findings indicate that hyperandrogenism disrupts adipokine signaling in a follicle-dependent manner, with differential expression patterns contributing to altered follicular maturation and cyst formation. The enhanced activation of adiponectin, apelin, and leptin signaling observed in cystic follicles may indicate disrupted adipokine-mediated regulation of ovarian physiology in letrozole-induced PCOS. Given the established roles of these adipokines in folliculogenesis and steroidogenesis, their dysregulation may contribute to follicular arrest and impaired ovarian function. These alterations are likely reflective responses to an altered endocrine and metabolic environment rather than direct causal mechanisms. Nonetheless, they may participate in the pathophysiological processes underlying cyst formation in PCOS.

#3

Mycophenolate mofetil versus prednisone for the initial treatment of idiopathic steroid-sensitive nephrotic syndrome in children in Germany (INTENT): a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial.

The Lancet. Child &amp; adolescent health2026 Mar 16

Prolonged glucocorticoid therapy is the standard initial treatment for idiopathic nephrotic syndrome in children, but is associated with marked toxic effects. We aimed to assess whether a novel treatment protocol with mycophenolate mofetil is as effective as standard therapy with prednisone, while reducing the burden of glucocorticoid-related side-effects. INTENT was a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial done in 37 community, municipal, and university hospitals in Germany. Patients aged 1-10 years with a first episode of steroid-sensitive nephrotic syndrome were randomly assigned (1:1) by a centralised web-based tool to receive either mycophenolate mofetil or prednisone (standard treatment), after remission induced by prednisone or prednisolone at a dose of 60 mg/m2 body surface area (maximum 80 mg/day) within 28 days. Block randomisation (block size of eight) was stratified by age (<7 years or ≥7 years). Mycophenolate mofetil was given at 1200 mg/m2 body surface area per day, twice daily, as a suspension (200 mg/mL) for a total treatment duration of 12 weeks. Prednisone was administered once, twice, or three times daily for 6 weeks at 60 mg/m2 body surface area per day (maximum 80 mg). Thereafter, prednisone was given for a further 6 weeks at 40 mg/m2 body surface area (maximum 60 mg) once daily in the morning on alternate days. The primary endpoint was the occurrence of a treated relapse during the 24-months of follow-up in the modified intention-to-treat population. The non-inferiority margin was 15%. This trial is registered with the European Union Drug Regulating Authorities Clinical Trials database (EudraCT 2014-001991-76) and has been completed. Between Oct 12, 2015, and April 23, 2021, 497 patients were screened for eligibility, 272 of whom were randomly assigned (136 to each group). The modified intention-to-treat population comprised 269 patients, of whom 173 (64%) were boys and 96 (36%) were girls (median age 4·0 years [IQR 2·0-5·0]). Mycophenolate mofetil was non-inferior to prednisone for the primary endpoint of treated relapse (106 [79·1%] of 134 vs 101 [74·8%] of 135; difference 4·3% [90% CIs -4·2 to 12·7]; p=0·019). At the end of the first 12 weeks of treatment, fewer glucocorticoid-related side-effects were observed in the mycophenolate mofetil group than the prednisone group, including arterial hypertension (78 [59·1%] of 132 vs 115 [87·1%] of 132; difference -28·0% [95% CI -37·7 to -17·5]), lower BMI (BMI Z score 0·16 [SD 0·85] vs 1·41 [1·02]; difference -1·24 [-1·47 to -1·02]), and fewer psychological abnormalities (37 [27·8%] of 133 vs 77 [57·9%] of 133; difference -30·1% [-40·9 to -18·4]). More patients in the mycophenolate mofetil group than in the prednisone group developed infections (93 [69·9%] of 133 vs 74 [55·6%] of 133; difference 14·3% [2·7 to 25·5]) and there was no statistically significant difference in the number of patients who developed at least one gastrointestinal disorder (22 [16·5%] of 133 vs 13 [9·8%] of 133; difference 6·8% [-1·5 to 14·8]). Our findings suggest that mycophenolate mofetil is non-inferior to standard prednisone treatment, with reduced glucocorticoid-related toxic effects. These findings could modify the initial standard of care for patients with steroid-sensitive nephrotic syndrome. German Federal Ministry of Education and Research.

#4

A Diagnostic Dilemma: Concurrent Diagnosis of Cystic Fibrosis and Definitive Kabuki Syndrome Type 1.

International journal of molecular sciences2026 Mar 09

The article presents a clinical case involving a patient with presumptive coexistence of two hereditary disorders, confirmed by molecular genetic analyses. Clinical evaluation of the proband, a 9-year-old girl, revealed features characteristic of Kabuki syndrome, including a typical "Kabuki makeup" facial phenotype, short stature, intracranial hypertension, and diffuse muscular hypotonia. Additional clinical findings included chronic right-sided otitis media, conjunctivitis, recurrent pneumonia, bilateral conductive hearing loss, astigmatism, and primary adenitis. Clinical assessment and molecular genetic testing were performed. High-throughput sequencing identified a previously reported pathogenic heterozygous variant in the KMT2D gene, NM_003482.4:c.15142C>T p.Arg5048Cys, and two known heterozygous variants in the CFTR gene: NM_000492.4:c.1521_1523delCTT p.Phe508del and c.3454G>C p.Asp1152His, classified as pathogenic and of variable clinical significance, respectively. Segregation analysis demonstrated that the KMT2D variant most likely arose in the proband de novo, whereas the CFTR variants were inherited from each of the parents. Notably, the proband's clinically unaffected elder sister carried the same CFTR genotype. Based on the clinical presentation and molecular genetic findings, the diagnosis of Kabuki syndrome type 1 was conclusively established in the patient. Functional assessment of CFTR demonstrated its preserved function, which did not support a diagnosis of CF or CFTR-related disorders.

#5

Toward Understanding the Role of miRNAs in Cleft Palate Only: Observations from Patient Tissues and In Vitro Assays.

International journal of molecular sciences2026 Feb 24

Cleft palate only (CPO) is a multifactorial craniofacial malformation with significant genetic and epigenetic contributions. Among these, microRNAs (miRNAs) have emerged as key regulators of palate development, although their alterations in CPO remain incompletely characterized. In this study, we performed a comprehensive miRNA expression analysis on palatal tissues from an Italian cohort of non-syndromic CPO patients, compared with a human embryonic palatal mesenchymal (HEPM) cell line. Using the NanoString® nCounter® platform for miRNA profiling, we identified significant deregulation of several miRNAs, notably the upregulation of miR-205-5p and miR-200c-3p and the downregulation of miR-125a-5p in CPO tissues. Based on these expression changes, a functional analysis was carried out to identify potential target genes. Validation in primary cell cultures derived from patient tissues confirmed these expression patterns. Functional analyses and target predictions implicated PAX9, a key transcription factor essential for palatogenesis, as a probable target of miR-205-5p, while miR-125a-5p was associated with the regulation of PRTG and PRSS35-genes involved in neural crest cell biology and extracellular matrix remodeling, respectively. Although modulation of certain predicted targets of miR-200c-3p was observed, in vitro inhibition experiments did not show significant changes in gene expression, highlighting the complexity of miRNA regulatory networks and the need for further studies to unravel these interactions. These findings identify miRNA alterations associated with CPO tissue and fibroblasts, highlighting novel candidate pathways for further mechanistic and therapeutic investigation.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

Metabolic syndrome and serum uric acid level in children and adolescents with hypertension.

Journal of hypertension
2026

Tau pathology in epilepsy: emerging mechanisms and translational opportunities.

Brain : a journal of neurology
2026

Tailored Charles' Procedure and Vascularized Lymph Node Transfer for Advanced Stage Klippel-Trenaunay Syndrome.

Acta chirurgica Belgica
2026

Trousseau's syndrome with cerebral infarction as the first manifestation.

American journal of translational research
2026

Case Report: Maculopathy following standard dose intracameral cefuroxime injection during ICL surgery.

Frontiers in ophthalmology
2026

Prevalence and Risk of Falls and Fractures in the Idiopathic Inflammatory Myopathies: A Cross-Sectional Study of 470 Patients.

Rheumatology and therapy
2026

PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial.

Trials
2026

Partial Anomalous Pulmonary Venous Return in Lung Cancer Surgery: Diagnostic Challenges and Surgical Considerations in Two Cases.

The Tokai journal of experimental and clinical medicine
2026

Multiple primary melanomas with numerous pink-to-tan papules and polydactylous onychopapillomas.

JAAD case reports
2026

Case Report: a 28-year-old female patient presented with recurrent fevers and episodes of shock due to ZBTB24 pathogenic variant.

Frontiers in immunology
2026

Nonatherosclerotic Subclavian Steal Syndrome Due to Brachiocephalic Trunk Kinking in an Elderly Woman: A Case Report.

The American journal of case reports
2026

Follicle-dependent differential localization of adipokines in the letrozole-induced hyperandrogenized mouse ovary.

Histochemistry and cell biology
2026

[Mutation characteristics and prognosis of patients with Fanconi anemia signaling pathway gene mutation myeloproliferative neoplasm].

Zhonghua yi xue za zhi
2026

Mycophenolate mofetil versus prednisone for the initial treatment of idiopathic steroid-sensitive nephrotic syndrome in children in Germany (INTENT): a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial.

The Lancet. Child &amp; adolescent health
2026

The Optimal Management Strategy for IGA Nephropathy Patients With Different Clinical Presentations.

Nephrology (Carlton, Vic.)
2026

Efficacy of device-measured physical activity on cardiometabolic outcomes among individuals with abnormal glucose tolerance in Ghana: A pilot randomized controlled trial.

Global epidemiology
2026

Adipose tissue distribution and metabolic profile of young individuals with turner syndrome.

Journal of the Endocrine Society
2026

Symptomatic improvement in fibromyalgia after treatment of comorbid attention deficit hyperactivity disorder: a case report.

Journal of medical case reports
2026

Integrated molecular and clinical profiling of primary mitochondrial oxidative phosphorylation disorders in an Indian cohort: Insights from genetics, neuroimaging, and machine learning.

Mitochondrion
2026

[Effect of the Degree of Myelofibrosis on the Therapeutic Efficacy and Survival in Patients with Myelodysplastic Syndromes].

Zhongguo shi yan xue ye xue za zhi
2026

Clinical Profile and Surgical Outcomes of Bilateral Duane Syndrome with Exotropia.

Journal of binocular vision and ocular motility
2026

Utility of the Early Sjögren Antibody Panel as a Diagnostic Marker for Sensory Neuropathy.

Muscle &amp; nerve
2026

An unusual presentation of portal biliopathy manifesting as chronic abdominal pain as a delayed post-splenectomy complication: a case report.

International journal of surgery case reports
2026

Syndromic Inborn Errors of Immunity in TREC-Newborn Screening: 5-year Experience from the German Screening Program.

Journal of clinical immunology
2026

MaiMenDong Decoction Alleviates Primary Sjögren's Syndrome by Dual Suppression of Inflammation and Immune Dysregulation: A Synergy of Network Pharmacology and NOD/Ltj Mouse Studies.

Combinatorial chemistry &amp; high throughput screening
2026

A Diagnostic Dilemma: Concurrent Diagnosis of Cystic Fibrosis and Definitive Kabuki Syndrome Type 1.

International journal of molecular sciences
2026

Toward Understanding the Role of miRNAs in Cleft Palate Only: Observations from Patient Tissues and In Vitro Assays.

International journal of molecular sciences
2026

Persistent physical symptoms not explained by structural abnormalities or disease processes: a primary care approach to promote recovery.

Scandinavian journal of primary health care
2026

Predictive factors for severity and poor treatment response in children with Evans syndrome: A retrospective cohort study.

Frontiers in immunology
2026

Efficacy and safety of Dysmenorrhea Patch acupoint application in women with primary dysmenorrhea: a randomized double-blind controlled trial.

Frontiers in endocrinology
2026

Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus Classification.

Blood cancer journal
2026

[Guidelines for the diagnosis and treatment of obstructive sleep apnea in adults (2025)].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2026

Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension associated with unrepaired congenital shunts (atrial septal defect, ventricular septal defect or patent ductus arteriosus), including Eisenmenger syndrome: the SuMILE trial.

BMJ open
2026

The tight bond between Fanconi anemia and aging.

Frontiers in aging
2026

Immunophenotypic Stratification of Primary Sjögren's Syndrome Reveals Distinct Lymphocyte Profiles and Clinical Manifestations.

Journal of immunology research
2026

Expanding the phenotypic and immunological landscape of Alazami syndrome: Evidence from seven new patients with LARP7 gene variants.

European journal of pediatrics
2026

Predictive value for intravenous immunoglobulin resistance of Kobayashi and Kawanet scores in 722 children with Kawasaki disease across diverse ethnic backgrounds (KIWI study): an international cohort study.

EClinicalMedicine
2026

QT Myopia and Cardiac Safety: Expanding the Aperture of Arrhythmia Assessment in Early Phase Drug Development.

Clinical and translational science
2026

De Novo 3q27.1 Microdeletion Refines the Critical Region and Implicates PSMD2 Haploinsufficiency in Growth and Neurodevelopmental Abnormalities.

American journal of medical genetics. Part A
2026

Case Report: Whole-genome sequencing of urothelial carcinoma in an adult patient with CLOVES syndrome reveals a lack of PIK3CA mutation and a genomic landscape consistent with urothelial carcinoma.

Frontiers in oncology
2026

Results of a Phase 1 Study Assessing the Effect of CIN-102, a Novel Formulation of the Dopamine Receptor Antagonist Domperidone Designed to Treat Gastroparesis, on Cardiac Repolarization in Healthy Volunteers.

Clinical pharmacology in drug development
2026

A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression Disorder.

Neurology and therapy
2026

A Novel Model System to Identify Cellular and Molecular Defects Underlying Rare Genetic Disorders.

Experimental dermatology
2026

Once-weekly somapacitan in children with Noonan syndrome: randomized controlled phase 3 trial.

European journal of endocrinology
2026

Estrogen deficiency and risk of hearing loss in pediatric Turner syndrome.

The Journal of clinical investigation
2026

Do Patients With Cleft Lip and Palate Have an Increased Risk of Short-Term Complications After Le Fort I Osteotomy?

The Journal of craniofacial surgery
2026

"Pediatric Brown syndrome in the setting of hypercholesterolemia: case report of a possible new association".

Strabismus
2026

Clinical and cost-effectiveness of eculizumab withdrawal in atypical haemolytic uraemic syndrome: the SETS aHUS multi-centre, open-label, prospective and single-arm study.

Health technology assessment (Winchester, England)
2026

Retinal detachment in patients with Sticklers syndrome: A comprehensive analysis for craniofacial surgeons.

JPRAS open
2026

Intersecting Autoimmunities: ANCA and Anti-GBM Overlap in a Patient With Sjögren's Disease.

Case reports in nephrology
2026

Primary membranoproliferative glomerulonephritis: natural history, pathogenesis, and treatment.

Frontiers in nephrology
2026

[Kallmann syndrome in a girl caused by a novel CHD7 variant].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2026

Acquired bisalbuminemia associated with hepatobiliary disease: a two-case report and diagnostic implications.

Laboratory medicine
2026

Delayed diagnosis of Waardenburg syndrome type 1 in a Syrian adult: Challenges and lessons from resource-limited settings, a case report and literature review.

Science progress
2026

Understanding atrial failure: from diagnosis to clinical implications.

Nature reviews. Cardiology
2026

Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trial.

BMJ open
2026

Evaluating the real-world safety of cholestyramine for the treatment of hyperlipidemia: disproportionality analysis of FAERS data.

Frontiers in medicine
2026

[When kidney disease is genetic: clues for the primary care physician].

Revue medicale suisse
2026

Transcranial Magnetic Stimulation in Parkinson's Disease and Parkinsonian Syndromes: A Narrative Expert Review.

Life (Basel, Switzerland)
2026

RNAi-Induced Expression of Paternal UBE3A.

Genes
2026

Mitochondria-Associated MicroRNAs: Emerging Roles in the Pathogenesis of Parkinson's Disease.

Biomedicines
2026

Development of a Predictive Model for Cardiac Dysfunction in MIS-C Patients Utilizing Laboratory Biomarkers.

Children (Basel, Switzerland)
2026

Splicing variants in MYRF cause partial loss of function in the retinal pigment epithelium leading to nanophthalmos.

JCI insight
2026

Neck Circumference as a Practical Anthropometric Biomarker for Visceral Adiposity and Metabolic Dysregulation in Type 2 Diabetes.

Metabolites
2026

A giant hiatal hernia with a congenital diaphragmatic hernia in a pediatric patient with arterial tortuosity syndrome: a case report.

Frontiers in pediatrics
2026

Familial pneumothorax in twins with Tatton-Brown-Rahman DNMT3A overgrowth syndrome.

European journal of human genetics : EJHG
2026

Educational Attainment of Children With Major Congenital Anomalies During Primary School in England: A Population Cohort Study.

Paediatric and perinatal epidemiology
2026

Congenital core myopathy linked to SOX5: Expanding the phenotypical spectrum of Lamb-Shaffer syndrome.

Journal of neuromuscular diseases
2026

Clinical Spectrum of Cutaneous, Ocular, and Hair Manifestations in Patients With Inborn Errors of Immunity: Insights From a Single Center in Turkey.

Immunity, inflammation and disease
2026

Seronegative Autoimmune Encephalitis With Neuropsychiatric Presentation: A Case Report.

Cureus
2026

A Case of Prostatic Mixed Germ Cell Tumor Showing Pagetoid Spread Into the Vas Deference in a Patient With Klinefelter Syndrome.

Pathology international
2026

Neutrophil extracellular traps in gynecological disease: pathogenic mechanisms and therapeutic opportunities.

Frontiers in medicine
2026

Cardiogenic shock managed with phlebotomy: an unusual case of end-stage cardiac hemochromatosis.

European heart journal. Case reports
2026

Unmasking Wilson's Disease Through Severe Psychiatric Manifestations: A Case Report.

Cureus
2025

Trisomy 13 as a risk factor for pulmonary hypertension induced by diazoxide.

Annals of pediatric cardiology
2025

A pediatric case of idiopathic harlequin syndrome.

Dermatology online journal
2026

Clinical Characteristics and Management of Two Cases of Complete Androgen Insensitivity Syndrome With Germ Cell Tumors.

Cancer reports (Hoboken, N.J.)
2026

Corrigendum "Role of reactive oxygen species in polycystic ovary syndrome: Signalling pathways, mechanisms, and traditional Chinese medicine treatment strategies" [Int. Immunopharmacol. 173 (2026) 116251].

International immunopharmacology
2026

Altered Brain Structure in an ATRX-Deficient Mouse Model of Autism Spectrum Disorder.

Autism research : official journal of the International Society for Autism Research
2026

Familial cartilage-hair hypoplasia: prenatal ultrasound features and clinical outcomes in three siblings with identical RMRP variants.

BMJ case reports
2026

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

American journal of human genetics
2026

Comprehensive in silico analysis of genetic landscape and pathways involved in Stickler syndrome.

PloS one
2026

Protective role of PASH-1 in CGG repeat-driven RNA and protein toxicity in FXTAS.

iScience
2026

Effects of Catecholamines on Bone and Mineral Metabolism in Patients with Pheochromocytoma and Paraganglioma.

The Journal of clinical endocrinology and metabolism
2026

A case report on atypical chromosomal variations in Turner syndrome.

Molecular cytogenetics
2025

A rare case of Kallmann syndrome in a female with pulmonary valve stenosis: Coincidence or genetic link?

La Tunisie medicale
2026

In vivo base editing of Chd3 rescues behavioural abnormalities in mice.

Nature
2026

Non-thyroidal illness (euthyroid sick) syndrome: Laboratory aspects and clinical significance in critically ill patients and other diseases - A narrative review.

Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures)
2026

Setmelanotide in Bardet-Biedl Syndrome: A 52-Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort.

Obesity (Silver Spring, Md.)
2026

The importance of comprehensive diagnostic work-up and genetic testing to reveal Andersen-Tawil syndrome-a case report.

European heart journal. Case reports
2025

Case Report: Nephrocalcinosis from pancreatic hypoplasia in HNF1B disease: a multigenerational expression with genetic confirmation in the youngest generation.

Frontiers in medicine
2026

Outcomes of Abdominal Exploration in ECMO-Supported Patients: A Multicenter ICU Cohort Study.

Journal of cardiothoracic and vascular anesthesia
2026

Differential disruption of gonadal development by DEHP and paracetamol in male and female Wistar rats.

Reproductive toxicology (Elmsford, N.Y.)
2026

The landscape of chromosomal aberrations in couples seeking assisted reproductive treatment.

Human reproduction (Oxford, England)
2026

Clinical Heterogeneity in a Scandinavian FMR1 Premutation Carrier Cohort and Basal Ganglia Atrophy in FXTAS.

Cerebellum (London, England)
2026

Left Ventricular Noncompaction Syndrome.

Cardiology in review
2026

The CARMUCI Study Design: A Double-Blind, Cross-Over Sham-Controlled Trial of Indoor Air Purification in People With Cystic Fibrosis and Primary Ciliary Dyskinesia.

Pediatric pulmonology
2026

Open Fetal Versus Postnatal Repair of Spina Bifida Aperta-A Comparison of Neonatal Outcomes.

Prenatal diagnosis
2026

Quantitative Understanding of Advanced Novel Imaging Techniques for Fasciitis and Biosignature Yield (Quantify): Protocol for a Cross-Sectional Diagnostic Study.

JMIR research protocols
2026

Secondary Thoracoabdominal Aortic Replacement Following Total Arch Repair With a Sutureless Integrated Stented Graft in Marfan Syndrome: A Case Report.

The American journal of case reports
2026

Hemophagocytic Lymphohistiocytosis Secondary to Immunotherapy Toxicity in a Patient With Breast Cancer: A Case Report.

Cureus
2026

Prognostic Stratification Based on Left Ventricular Diastolic Dysfunction and Coronary Microvascular Dysfunction in Patients Without Functional Coronary Artery Stenosis.

Circulation reports
2026

A Pediatric Case of Stiff-Person Syndrome: Presentation and Comparative Analysis.

Journal of orthopaedic case reports
2026

Nager Syndrome Revisited: Integrating In Vivo and In Vitro Models to Decipher SF3B4-Dependent Tissue Coordination.

WIREs mechanisms of disease
2026

Aicardi-Goutières Syndrome caused by SAMHD1 mutation: Pathogenesis and Beyond.

Clinical immunology (Orlando, Fla.)
2026

Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial.

The lancet. HIV
2026

Molecular convergence enables precision medicine for pediatric low grade gliomas.

Discover oncology
2025

[Role of hyaluronic acid synthases in female infertility-related diseases].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
2026

Successful Treatment of Multifocal Demyelinating Sensory-Motor Neuropathy (Lewis-Sumner Syndrome) With Rituximab: A Case Report.

The American journal of case reports
2026

Unraveling the Mechanistic Spectrum of Myhre Syndrome: SMAD4 Signaling Disruption, Skeletal Phenotypes, and Translational Innovation.

American journal of medical genetics. Part C, Seminars in medical genetics
2026

Impact of β-Blockers on the Risk of Low-Birth-Weight Infants in Women with Long QT Syndrome or Marfan Syndrome: A Single-Center Retrospective Study from 2008 to 2022 in a Tertiary Care Center.

Paediatric drugs
2026

Endocrine Hypertension: The Role of Imaging in Diagnosis and Management.

The British journal of radiology
2026

Menstrual Dysfunction Is Associated With Elevated Liver Enzymes in Adolescent Females: A United States Population-Based Study.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine
2025

Epigenetic disruption meets immune deficiency: a case report of ICF syndrome linked to DNMT3B mutation.

Frontiers in immunology
2025

[Analysis of a child with You-Hoover-Fong syndrome due to compound heterozygous variants of the TELO2 gene and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

[Analysis of DNAH11 gene variants and clinical characteristics of a Chinese pedigree affected with Primary ciliary dyskinesia].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Postpartum reversible cerebral vasoconstriction syndrome: a rare but severe cause of postpartum headache.

BMJ case reports
2026

Presentation and Outcomes of CNS Tumors Associated With Phakomatoses Syndromes From a Specialized Neuro-Oncology Practice in India.

Cancer medicine
2025

[Van Wyk-Grombach syndrome as a result of late diagnosis of autoimmune thyroiditis (ait) in a patient with chromosome 22 deletion syndrome. Description of the clinical case and a brief review of the literature].

Problemy endokrinologii
2026

Renal biopsy findings in psoriasis patients with renal involvement: a descriptive clinicopathologic study.

BMC nephrology
2026

Clinicopathologic and Molecular Features of Tubo-Ovarian Carcinosarcomas With an Emphasis on p53 Wild-Type, KRAS-Mutated Tumors.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2025

Hypomagnesemia as a primary clue for the diagnosis of 17q12 deletion syndrome associated with spinal syringomyelia: a case report.

The Turkish journal of pediatrics
2026

Neurotransmitter abnormalities in primary tic disorders and Tourette syndrome.

Handbook of clinical neurology
2026

Incidence of Ocular Abnormalities in Metopic Craniosynostosis: Cranial Vault Reconstruction Versus Endoscopic Suturectomy.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2026

What's new about angiotensin receptor blocker (ARB) therapy for Marfan syndrome: A narrative review.

Vascular medicine (London, England)
2026

A Case of Complex Syndactyly with Apert Syndrome Treated with a Two-stage Interdigital Reconstruction Using Adipose Flaps.

Journal of plastic and reconstructive surgery
2026

Electrodiagnostic Approach to Defects of Neuromuscular Transmission.

Muscle &amp; nerve
2026

[Key updates in the 2025 ERS/ATS guideline for the diagnosis of primary ciliary dyskinesia].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2026

[Expert consensus on diagnosis and treatment of adult primary ciliary dyskinesia (2025 edition)].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2026

Prenatal diagnosis of distal Xq28 duplication syndrome: case reports and literature review.

Molecular cytogenetics
2026

Effects of Ziziphus jujuba, metformin, and myoinositol on pregnancy rates and metabolic parameters in infertile women with PCOS: a randomized controlled trial.

Journal of ovarian research
2026

Neonatal erythroderma and immunodysplasia: Overlap of cartilage-hair hypoplasia and Omenn syndrome.

European journal of medical genetics
2026

Vanishing twin syndrome and fetal reduction adversely affect perinatal outcomes following IVF-FET: an analysis based on 33,238 ongoing pregnancies.

Journal of assisted reproduction and genetics
2026

Long-Term Outcomes and Risk Factors for Mortality After Single Ventricle Palliation for Asplenia Syndrome.

Journal of the American Heart Association
2026

Evaluating the patterns of use and safety of lenalidomide treatment in myelodysplastic syndromes: a European, observational multi-registry study.

Therapeutic advances in drug safety
2025

Atypical Presentation of a Preeclamptic Patient With Severe Features and Auditory Hallucinations.

Cureus
2025

Simultaneous occurrence of bilateral retroperitoneal neuroblastoma and bifocal malignant mixed germ cell tumor in a pediatric patient with 16p11.2 microdeletion syndrome: a case report.

Frontiers in endocrinology
2026

Dose-Dependent Effect of the Histamine 1 Receptor Antagonist Ebastine in Patients With Non-Constipated Irritable Bowel Syndrome.

Neurogastroenterology and motility
2025

Case Report: Van Wyk-Grumbach syndrome presenting as vaginal bleeding: diagnostic value of pituitary and pelvic imaging.

Frontiers in pediatrics
2025

Prevention of Respiratory Infections in Children with Congenital Heart Disease: Current Evidence and Clinical Strategies.

Vaccines
2026

Directions and Perspectives for Preventive Activities in Primary Care-Patients' Health-Promoting and Health-Risk Behaviours.

Nutrients
2026

Implementation of an Electronic Medical Record-Embedded Refeeding Risk Order Set and Its Impact on Refeeding Syndrome Among Adults Receiving Enteral Nutrition: A Retrospective Cohort Study in an Inpatient Hospital Setting.

Nutrients
2025

Digital Technologies in Diagnosing Solitary Median Maxillary Central Incisor Syndrome.

Children (Basel, Switzerland)
2026

Recent advances in the mechanisms and treatment of cuproptosis in autoimmune diseases.

Autoimmunity reviews
2026

Platelet activation, aspirin, and cancer: From basic science to clinical trials.

Pharmacological reviews
2026

Occlusal Dysesthesia (Phantom Bite Syndrome): A Scoping Review.

Dentistry journal
2026

Current understanding of mitral valve prolapse syndrome and related arrhythmia: State-of-the-Art Review.

Kardiologia polska
2026

Microglia replacement by ER-Hoxb8 conditionally immortalized macrophages provides insight into Aicardi-Goutières syndrome neuropathology.

eLife
2025

Rodent models of genetic epilepsy and its association with neurocognitive impairment- a systematic review.

Frontiers in pharmacology
2026

CTLA-4 haploinsufficiency presenting with chronic myeloid leukemia, bullous pemphigoid, and PLA2R-positive membranous nephropathy: a case report.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
2026

Sputum from Individuals with Primary Ciliary Dyskinesia Drives M2-like Macrophage Polarization.

Lung
2026

Role of reactive oxygen species in polycystic ovary syndrome: signalling pathways, mechanisms, and traditional Chinese medicine treatment strategies.

International immunopharmacology
2026

Integration of focused cardiac ultrasound in the HEAR and HEART scores in emergency department patients with chest pain.

Internal and emergency medicine
2026

Clinical, Psychosocial, and Care Coordination Concerns in Macrocephaly Capillary Malformation Syndrome: Insights From a Large International Survey.

Pediatric blood &amp; cancer
2025

Beyond Snoring: Unexpected Presentation of Obstructive Sleep Apnea.

Cureus
2026

Sleep-Disordered Breathing in Newborns After Myelomeningocele Repair.

Pediatrics
2025

Under Pressure: Increased Intracranial Pressure in Infants and Children. Presented at the 2024 AOC/AACO/AAO Sunday Symposium.

Journal of binocular vision and ocular motility
2026

Clinical characteristics and severity of primary ciliary dyskinesia caused by large homozygous deletion including exons 1-4 of DRC1: A multicenter retrospective cohort study.

Respiratory investigation
2026

Efficacy of radiotherapy and role of adjunctive immunochemotherapy in POEMS syndrome with solitary plasmacytoma.

Blood advances
2025

Quantifying the risks: a systematic review and proportional meta-analysis of the perioperative complications of posterior cranial vault distraction osteogenesis in patients with craniosynostosis.

Journal of neurosurgery. Pediatrics
2026

Seizure outcomes after VNS therapy in children with drug-resistant epilepsy due to monogenic etiologies versus malformations of cortical development.

Journal of neurosurgery. Pediatrics
2026

Immune thrombocytopenia in patients with connective tissue disease.

Clinical rheumatology
2026

The Diagnostic and Prognostic Role of Ultrasonography in Cubital Tunnel Syndrome: Results on a Consecutive Series of 100 Patients.

Neurosurgery
2025

Copy number variation: an important genetic mechanism in SMARCAL1-related immunoosseous dysplasia (Schimke type) in Indian patients.

Journal of genetics
2025

Effect of electroacupuncture on metabolic level and quality of life in patients with obese polycystic ovary syndrome: a randomized controlled trial.

Frontiers in endocrinology
2026

Sex Hormones and Repolarization Dynamics During the Menstrual Cycle in Women Treated With QT-Prolonging Drugs.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2026

Behçet-like Syndromes: A Comprehensive Review.

Dermatopathology (Basel, Switzerland)
2026

Unraveling the Genetic Mysteries of Müllerian Anomalies: Research Approaches and Clinical Significance.

Clinical genetics
2026

Genetic and Clinical Features of FOXL2-Associated Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Based on 11 Chinese Families and Literature Review.

American journal of medical genetics. Part A
2025

Coronary artery abnormalities in Kawasaki disease with BCG site reactivation.

European journal of pediatrics
2026

Advanced-Stage Gonadal Dysgerminoma in a Patient With a Previous Diagnosis of Familial Swyer Syndrome: A Very Rare Genetic Entity.

Case reports in medicine
2026

A Thorough QT Study to Assess the Effects of Milvexian on Cardiac Repolarization in Healthy Participants.

Clinical pharmacology in drug development
2025

Investigation of a raised ferritin-hereditary haemochromatosis or not?

QJM : monthly journal of the Association of Physicians
2026

[Clinical analysis of neurologic complications in neonates during extracorporeal membrane oxygenation support].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2026

Generation of induced pluripotent stem cells from a patient with CHARGE syndrome with athymia, harboring a heterozygous mutation in CHD7.

Stem cell research
2025

Granulomatous Lymphocytic Interstitial Lung Disease as the Initial Manifestation of Common Variable Immunodeficiency in a Young Adult.

Cureus
2026

Primary pulmonary hypoplasia masquerading as pneumonia in a preterm neonate and creating a diagnostic challenge: a case report.

Journal of medical case reports
2026

Fertility preservation and counselling in prepubertal and pubertal girls with Turner syndrome.

Human reproduction (Oxford, England)
2025

Low-Grade B-cell Lymphoma in Primary Sjögren's Syndrome: A Case Report.

Cureus
2026

Alport Syndrome is a Partial Tubulointerstitial Disease of the Kidney.

Kidney international reports
2026

Functional imaging reveals cerebral microvascular dysfunction in primary antiphospholipid syndrome: Pathophysiologic insights and translational implications.

Journal of the neurological sciences
2026

Prevalence of Central Sensitization in Postural Tachycardia Syndrome.

JAMA network open
2026

Resolution of Noncardiogenic Pulmonary Oedema and Suspected Uraemic Pneumonitis in a Dog With Acute Kidney Injury Treated by Haemodialysis.

Veterinary medicine and science
2026

Management of hypoparathyroidism during pregnancy following late maternal diagnosis of DiGeorge syndrome: a case report.

Journal of medical case reports
2026

Sutureless Intrascleral One-piece Intraocular Lens Fixation for Ectopia Lentis in Marfan Syndrome.

Journal of refractive surgery (Thorofare, N.J. : 1995)
2026

Antibody Deficiency in Xeroderma Pigmentosum.

Journal of clinical immunology
2026

Mayer-Rokitansky-Kuster-Hauser Syndrome: From Radiological Diagnosis to Further Challenges-Review and Update.

Diagnostics (Basel, Switzerland)
2025

A Critical Assessment of Antenatal Monitoring for Fetal Well-Being in Down Syndrome Pregnancies.

Diagnostics (Basel, Switzerland)
2026

Identification of ACBP as a potential target in ciliopathic obesity through multi-omics network analysis.

Nature communications
2026

Improvement of severe hypertriglyceridemia in atypical subtype 4 partial lipodystrophy with volanesorsen.

Journal of clinical lipidology
2026

Primary cilia and BBS4 are required for postnatal pituitary development.

Developmental biology
2025

A CASE OF REFRACTORY IRON DEFICIENCY ANEMIA REVEALING HEREDITARY HEMORRHAGIC TELANGIECTASIA.

Georgian medical news
2026

Incidental Finding of Secondary Focal Segmental Glomerulosclerosis in Renal Allograft due to Renal Artery Stenosis.

Pediatric transplantation
2025

[Randomized, double-blind, double-simulated, parallel controlled clinical trial of Dingkundan Oral Liquid in treating primary dysmenorrhea with cold coagulation and blood stasis].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
2026

Multi-omics identifies lipid accumulation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome cell lines: a case-control study.

Journal of translational medicine
2026

[A rare case of adrenal hemangioblastoma and literature review].

Zhonghua nei ke za zhi
2026

Pearls & Oy-sters: Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia.

Neurology
2026

Clinical characteristics of two companion canines with severe fever with thrombocytopenia syndrome virus (Bandavirus dabieense) in Seoul, Republic of Korea.

Veterinary research communications
2025

[Partial D2 receptors agonists - pharmacological aspects, metabolism and use in the treatment of schizophrenia-related psychoses].

Postepy biochemii

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Adenoma secretor de aldosterona com doença neuromuscular complexa.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Adenoma secretor de aldosterona com doença neuromuscular complexa

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Tau pathology in epilepsy: emerging mechanisms and translational opportunities.
    Brain : a journal of neurology· 2026· PMID 41871415mais citado
  2. Follicle-dependent differential localization of adipokines in the letrozole-induced hyperandrogenized mouse ovary.
    Histochemistry and cell biology· 2026· PMID 41857436mais citado
  3. Mycophenolate mofetil versus prednisone for the initial treatment of idiopathic steroid-sensitive nephrotic syndrome in children in Germany (INTENT): a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial.
    The Lancet. Child &amp; adolescent health· 2026· PMID 41856160mais citado
  4. A Diagnostic Dilemma: Concurrent Diagnosis of Cystic Fibrosis and Definitive Kabuki Syndrome Type 1.
    International journal of molecular sciences· 2026· PMID 41828725mais citado
  5. Toward Understanding the Role of miRNAs in Cleft Palate Only: Observations from Patient Tissues and In Vitro Assays.
    International journal of molecular sciences· 2026· PMID 41828317mais citado
  6. Genetic and non-genetic factors influencing phenotypic variability in neurofibromatosis type 1.
    Orphanet J Rare Dis· 2026· PMID 41987183recente
  7. Real-time breath metabolomics as catalyst for personalized lung cancer diagnostics: prospective matched case-control trial (LUCAbreath).
    Transl Lung Cancer Res· 2026· PMID 41982695recente
  8. The mutational burden in os odontoideum patients.
    Orphanet J Rare Dis· 2026· PMID 41981692recente
  9. European Reference Networks - a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025.
    Orphanet J Rare Dis· 2026· PMID 41981625recente
  10. Clinical characteristics and long-term prognosis of anti-MDA5-positive dermatomyositis: a comparative study across age groups.
    Orphanet J Rare Dis· 2026· PMID 41965859recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:369929(Orphanet)
  2. OMIM OMIM:615474(OMIM)
  3. MONDO:0014200(MONDO)
  4. GARD:17591(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55784730(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Adenoma secretor de aldosterona com doença neuromuscular complexa
Compêndio · Raras BR

Adenoma secretor de aldosterona com doença neuromuscular complexa

ORPHA:369929 · MONDO:0014200
Prevalência
<1 / 1 000 000
Casos
2 casos conhecidos
Herança
Not applicable
CID-10
E26.0 · Hiperaldosteronismo primário
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C3809609
Testes
8 disponíveis
Repurposing
22 candidatos
beclamideanticonvulsant
carbamazepinecarboxamide antiepileptic
eslicarbazepine-acetatesodium channel blocker
+17 outros
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades